Litcius/Paper detail

Novel drugs targeting EGFR and HER2 exon 20 mutations in metastatic NSCLC

Iosune Baraibar, Laura Mezquita, Ignacio Gil‐Bazo, David Planchard

2020Critical Reviews in Oncology/Hematology66 citationsDOI

Topics & Concepts

ExonEpidermal growth factor receptorCancer researchGefitinibMedicineTargeted therapyLung cancerTyrosine kinaseMutationOncologyBiologyGeneCancerInternal medicineReceptorGeneticsLung Cancer Treatments and MutationsCancer therapeutics and mechanismsHER2/EGFR in Cancer Research
Novel drugs targeting EGFR and HER2 exon 20 mutations in metastatic NSCLC | Litcius